Antibiotics in urology - New essentials

被引：4
作者：
Wagenlehner, F. M. E. [1 ]
Weidner, W. [1 ]
Naber, K. G. [2 ]
机构：
[1] Univ Giessen, Clin Urol & Pediat Urol, D-35385 Giessen, Germany
[2] Tech Univ Munich, D-94315 Straubing, Germany
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2008年 / 35卷 / 01期
关键词：
D O I：
10.1016/j.ucl.2007.09.002
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The bacterial spectrum and rates of antimicrobial resistance of uncomplicated community-acquired and complicated and nosocomially acquired urinary tract infections differ substantially. Significant variation exists from region to region and over time. On the other hand, antibiotics are widely used in urologic practice for the need of modern medicine; therefore, antibiotic substances are continuously evaluated for clinical usage. The use of antibiotics must keep up with continuous changes in antimicrobial resistance and be tailored to the needs of individual patients.
引用
收藏
页码：69 / +
页数：12
相关论文
共 67 条
[1]   INHIBITION OF PEPTIDOGLYCAN BIOSYNTHESIS IN GRAM-POSITIVE BACTERIA BY LY146032 [J].
ALLEN, NE ;
HOBBS, JN ;
ALBORN, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1093-1099
[2]  
[Anonymous], 1982, ANTIBIOTICS INTEGRAT
[3]   Diversity of TEM mutants in Proteus mirabilis [J].
Bonnet, R ;
De Champs, C ;
Sirot, D ;
Chanal, C ;
Labia, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2671-2677
[4]   A European perspective on nosocomial urinary tract infections I.: Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study) [J].
Bouza, E ;
San Juan, R ;
Muñoz, P ;
Voss, A ;
Kluytmans, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (10) :523-531
[5]  
BURCHALL JJ, 1982, REV INFECT DIS, V4, P246
[6]   SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae [J].
Chaves, J ;
Ladona, MG ;
Segura, C ;
Coira, A ;
Reig, R ;
Ampurdanés, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2856-2861
[7]   Intrapulmonary pharmacokinetics of linezolid [J].
Conte, JE ;
Golden, JA ;
Kipps, J ;
Zurlinden, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1475-1480
[8]  
Culebras Esther, 1999, Frontiers in Bioscience, V4, pD1, DOI 10.2741/culebras
[9]  
DEBRUIN MF, 2000, 4 DEC INT C NOS HEAL
[10]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
1234567